BONNEY MICHAEL W
SEC CIK 1219016 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | Dir | 16.8K | — | $15.23M | 9 | 2023-08-02 | 2025-08-18 |
Most active insiders at ALNY, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Greenstreet Yvonne | CEO, Dir | — | $24.46M |
| 2 | Fitzgerald Kevin Joseph | CSO, EVP, Head of Research | — | $10.74M |
| 3 | Garg Pushkal | EVP Chief R, D | — | $8.12M |
| 4 | Poulton Jeffrey V. | EVP, CFO | — | $4.95M |
| 5 | Tanguler Tolga | EVP, Chief Commercial Off | — | $3.06M |
| 6 | McLaughlin Melissa | CHRO | — | $1.27M |
| 7 | PYOTT DAVID E I | Dir | — | $1.15M |
| 8 | Reitan Colleen F | Dir | — | — |
| 9 | Sigal Charles Elliott | Dir | — | — |
| 10 | Arbuckle Stuart A | Dir | — | — |
BONNEY MICHAEL W made no open-market trades at ALNY in the last 12 months.
Transactions 9
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-08-19 | 2025-08-18 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | BONNEY MICHAEL W | Dir | S - Sale+OE | $450.00 | -11.2K | 16.8K | -40% | -$5.06M |
| D | 2025-08-19 | 2025-08-18 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | BONNEY MICHAEL W | Dir | M - OptEx | $70.20 | +11.2K | 28.1K | +67% | +$789.8K |
| DM | 2025-05-19 | 2025-05-15 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | BONNEY MICHAEL W | Dir | S - Sale+OE | $277.71 | -11.2K | 27.5K | -29% | -$3.12M |
| D | 2025-05-19 | 2025-05-15 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | BONNEY MICHAEL W | Dir | M - OptEx | $131.21 | +11.2K | 28.1K | +67% | +$1.48M |
| D | 2025-05-12 | 2025-05-08 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | BONNEY MICHAEL W | Dir | A - Grant | $0.00 | +775 | 16.8K | +5% | $0 |
| D | 2023-12-29 | 2023-12-27 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | BONNEY MICHAEL W | Dir | S - Sale+OE | $195.00 | -30.0K | 16.0K | -65% | -$5.85M |
| D | 2023-12-29 | 2023-12-27 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | BONNEY MICHAEL W | Dir | M - OptEx | $96.45 | +30.0K | 46.0K | +187% | +$2.89M |
| DM | 2023-08-04 | 2023-08-03 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | BONNEY MICHAEL W | Dir | S - Sale+OE | $185.38 | -6,448 | 16.5K | -28% | -$1.20M |
| D | 2023-08-04 | 2023-08-02 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | BONNEY MICHAEL W | Dir | M - OptEx | $0.00 | +22.5K | 22.5K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations